The USPTO has issued a Federal Register Notice discussing how the duty of candor and good faith in dealing with the USPTO applies to “information and statements material to patentability … received from or submitted to the FDA and other governmental agencies.” The Notice was issued in accordance with a July 2021 Executive Order and…